Acadia holder State Street reports 5.3% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
State Street Corporation has filed as a significant institutional holder of ACADIA PHARMACEUTICALS INC common stock. The filing reports that State Street beneficially owns 9,076,212 shares of common stock, representing 5.3% of the class.
State Street reports no sole voting or dispositive power, but shared voting power over 8,679,785 shares and shared dispositive power over 9,076,212 shares. Subsidiaries involved include SSGA Funds Management, Inc. and several State Street Global Advisors entities, indicating the holdings are managed across affiliated investment advisers.
Key Figures
Key Terms
beneficially owned financial
Investment Company Act of 1940 regulatory
parent holding company financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of ACAD (ACADIA PHARMACEUTICALS INC) does State Street Corporation report owning?
What dispositive power does State Street report over its ACAD common stock position?
Which State Street subsidiaries are associated with the ACAD (ACADIA PHARMACEUTICALS INC) holdings?
Does State Street report any other person having rights to ACAD dividends or sale proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.